Literature DB >> 12167349

Antibodies directed against an epitope in the N-terminal region of the H4L subunit of the vaccinia virus RNA polymerase inhibit both transcription initiation and transcription termination, in vitro.

Mohamed R Mohamed1, Linda A Christen, Edward G Niles.   

Abstract

The vaccinia virus virion RNA polymerase that is active in early gene transcription contains a unique subunit encoded by the H4L gene. Prior studies demonstrated that this protein is required both for early gene transcription initiation and for transcription termination. Polyclonal antibodies raised against H4L amino acids 1 to 256 prevent both initiation and termination of transcription, in vitro. Pretreatment of the anti-H4L antibody with a H4L fragment containing amino acids 1 to 99 prevents antibody inhibition of both steps, mapping the inhibitory antibody-binding site to this region. A combination of immunoprecipitation and competition studies of antibody binding to wild-type and site-specific mutations of H4L(1-195) mapped the strong epitope to a site that includes Y18. H4L fragments containing an Y18A mutation exhibit diminished ability to block antibody inhibition of transcription initiation and termination. Antibodies inhibit preinitiation complex (PIC) formation but not the activity of preformed PICs, indicating that this region of H4L interacts with one or more factors during active PIC formation. Furthermore, isolated H4L(1-195) directly inhibits PIC activity, supporting this model. Anti-H4L antibody inhibition of transcription termination is only observed in the absence of the essential termination cofactor NPH I. In contrast, antibody inhibition of PIC formation is unaffected by NPH I, demonstrating that the inhibitory antibody and NPH I can bind to H4L at the same time.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167349     DOI: 10.1006/viro.2002.1498

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

Review 1.  Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.

Authors:  Magdalini Moutaftsi; David C Tscharke; Kerrie Vaughan; David M Koelle; Lawrence Stern; Mauricio Calvo-Calle; Francis Ennis; Masanori Terajima; Gerd Sutter; Shane Crotty; Ingo Drexler; Genoveffa Franchini; Jon W Yewdell; Steven R Head; Janice Blum; Bjoern Peters; Alex Sette
Journal:  Future Microbiol       Date:  2010-02       Impact factor: 3.165

2.  Vaccinia virus early gene transcription termination factors VTF and Rap94 interact with the U9 termination motif in the nascent RNA in a transcription ternary complex.

Authors:  Linda A Christen; Sarah Piacente; Mohamed R Mohamed; Edward G Niles
Journal:  Virology       Date:  2008-05-01       Impact factor: 3.616

3.  Interaction of the vaccinia virus RNA polymerase-associated 94-kilodalton protein with the early transcription factor.

Authors:  Zhilong Yang; Bernard Moss
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

4.  Determinants of vaccinia virus early gene transcription termination.

Authors:  Sarah Piacente; Linda Christen; Benjamin Dickerman; Mohamed R Mohamed; Edward G Niles
Journal:  Virology       Date:  2008-04-22       Impact factor: 3.616

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.